162 related articles for article (PubMed ID: 15328521)
1. RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer.
Church RD; Yu J; Fleshman JW; Shannon WD; Govindan R; McLeod HL
Br J Cancer; 2004 Sep; 91(6):1015-8. PubMed ID: 15328521
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
Hsi LC; Angerman-Stewart J; Eling TE
Adv Exp Med Biol; 2002; 507():127-31. PubMed ID: 12664576
[No Abstract] [Full Text] [Related]
3. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
Vogiagis D; Brown W; Glare EM; O'Brien PE
Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
[TBL] [Abstract][Full Text] [Related]
4. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
[TBL] [Abstract][Full Text] [Related]
5. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
7. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
Gupta RA; Tan J; Krause WF; Geraci MW; Willson TM; Dey SK; DuBois RN
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13275-80. PubMed ID: 11087869
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 overexpression in colorectal cancer is associated with non-polypoid growth.
Tsunozaki H; Yoshinaga K; Kumagai J; Sugihara K
Jpn J Clin Oncol; 2002 May; 32(5):167-71. PubMed ID: 12110643
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer.
Dimberg J; Samuelsson A; Hugander A; Söderkvist P
Anticancer Res; 1998; 18(5A):3283-7. PubMed ID: 9858896
[TBL] [Abstract][Full Text] [Related]
12. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
13. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2001 Dec; 7(12):3971-6. PubMed ID: 11751489
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB.
Ramsay RG; Friend A; Vizantios Y; Freeman R; Sicurella C; Hammett F; Armes J; Venter D
Cancer Res; 2000 Apr; 60(7):1805-9. PubMed ID: 10766162
[TBL] [Abstract][Full Text] [Related]
16. The relationship between cyclooxygenase-2 expression and colorectal cancer.
Sheehan KM; Sheahan K; O'Donoghue DP; MacSweeney F; Conroy RM; Fitzgerald DJ; Murray FE
JAMA; 1999 Oct; 282(13):1254-7. PubMed ID: 10517428
[TBL] [Abstract][Full Text] [Related]
17. The role of cyclooxygenases in inflammation, cancer, and development.
Williams CS; Mann M; DuBois RN
Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of fatty acid cyclooxygenases-1 and -2.
Yamamoto S; Yamamoto K; Kurobe H; Yamashita R; Yamaguchi H; Ueda N
Int J Tissue React; 1998; 20(1):17-22. PubMed ID: 9561442
[TBL] [Abstract][Full Text] [Related]
19. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.
Fujita T; Matsui M; Takaku K; Uetake H; Ichikawa W; Taketo MM; Sugihara K
Cancer Res; 1998 Nov; 58(21):4823-6. PubMed ID: 9809985
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 transcription is stimulated and amylase secretion is inhibited in pancreatic acinar cells after induction of acute pancreatitis.
Zabel-Langhennig A; Holler B; Engeland K; Mössner J
Biochem Biophys Res Commun; 1999 Nov; 265(2):545-9. PubMed ID: 10558906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
